| Abstract | The efficacy of ranitidine 150 mg twice daily and Maalox TC three tablets four times daily were compared in patients with endoscopically confirmed duodenal ulcer. Seventy-nine patients were randomly allocated to double-blind, double-dummy treatment, stratified for smokers. Endoscopy was repeated after four weeks. Those unhealed continued treatment for a further two weeks before final endoscopy. Per protocol analysis in 53 patients showed ulcer healing rates at week 4 and at weeks 4 and 6 combined of 78 and 89% on Maalox TC, and of 81 and 91% on ranitidine, respectively. The same analysis gave overall healing rates of 81% in smokers and 100% in nonsmokers, irrespective of treatment. Both treatments provided early ulcer pain relief. Diarrhea was a commoner side effect in patients on Maalox TC. The study showed Maalox TC and ranitidine were equally effective in healing duodenal ulceration. |
| Authors | J O Hunter, R J Walker, J Crowe, R R Gillies, K R Gillies, K R Gough, S Lorber
(Affiliation: Gastroenterology Research Unit, Addenbrooke's Hospital, Cambridge, U.K.)
|
| Journal | Digestive diseases and sciences
(Dig Dis Sci)
Vol. 36
Issue 7
Pg. 911-6
(Jul 1991)
ISSN: 0163-2116 [Print] UNITED STATES |
| PMID | 2070704
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antacids
- Drug Combinations
- Magnesium Hydroxide
- Aluminum Hydroxide
- aluminum hydroxide, magnesium hydroxide, drug combination
- Ranitidine
|
| Topics |
- Adult
- Aged
- Aluminum Hydroxide
(adverse effects, therapeutic use)
- Antacids
(adverse effects, therapeutic use)
- Double-Blind Method
- Drug Combinations
- Duodenal Ulcer
(drug therapy)
- Female
- Humans
- Magnesium Hydroxide
(adverse effects, therapeutic use)
- Male
- Middle Aged
- Pain Measurement
- Ranitidine
(adverse effects, therapeutic use)
- Smoking
(adverse effects)
|